Literature DB >> 12167117

Apoptosis and cell proliferation in the development of gastric carcinomas: associations with c-myc and p53 protein expression.

Hideaki H Ishii1, Glenda C Gobé, Wenshen Pan, Juichi Yoneyama, Yoshiro Ebihara.   

Abstract

BACKGROUND AND AIM: Patients with gastric carcinomas have a poor prognosis and low survival rates. The aim of the present paper was to characterize cellular and molecular properties to provide insight into aspects of tumor progression in early compared with advanced gastric cancers.
METHODS: One hundred and nine graded gastric carcinomas (early or advanced stage, undifferentiated or differentiated type) with paired non-cancer tissue were studied to define the correlation between apoptosis (morphology, terminal deoxyribonucleotidyl transferase-mediated dUTP-digoxigenin nick end-labeling), cell proliferation (Ki-67 expression, morphology) and expression and localization of two proteins frequently having altered expression in cancers, namely p53 and c-myc.
RESULTS: Overall, apoptosis was lower in early stage, differentiated and undifferentiated gastric carcinomas compared with advanced-stage cancers. Cell proliferation was comparatively high in all stages. There was a high level of p53 positivity in all stages. Only the early- and advanced-stage undifferentiated cancers that were p53 positive had a significantly higher level of apoptosis (P < 0.05). Cell proliferation was significantly greater (P < 0.05) only in the early undifferentiated cancers that had either c-myc or p53-positivity.
CONCLUSIONS: The results indicate that low apoptosis and high cell proliferation combine to drive gastric cancer development. The molecular controls for high cell proliferation of the early stage undifferentiated gastric cancers involve overexpression of both p53 and c-myc. Overexpression of p53 may also control cancer development in that its expression is associated with higher levels of apoptosis in early and late-stage undifferentiated, cancers. Copyright 2002 Blackwell Publishing Asia Pty Ltd

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12167117     DOI: 10.1046/j.1440-1746.2002.02805.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  14 in total

1.  Expression of MTLC gene in gastric carcinoma.

Authors:  Guang-Bin Qiu; Li-Guo Gong; Dong-Mei Hao; Zhi-Hong Zhen; Kai-Lai Sun
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

2.  The impact of C-MYC gene expression on gastric cancer cell.

Authors:  Lin Zhang; Yanhong Hou; Hassan Ashktorab; Liucun Gao; Yanjie Xu; Kai Wu; Junshan Zhai; Lei Zhang
Journal:  Mol Cell Biochem       Date:  2010-08-25       Impact factor: 3.396

3.  Role of p53, apoptosis, and cell proliferation in early stage Epstein-Barr virus positive and negative gastric carcinomas.

Authors:  H H Ishii; G C Gobe; J Yoneyama; M Mukaide; Y Ebihara
Journal:  J Clin Pathol       Date:  2004-12       Impact factor: 3.411

4.  Depressed type of intramucosal differentiated-type gastric cancer has high cell proliferation and reduced apoptosis compared with the elevated type.

Authors:  Toshihiko Nakamura; Takashi Yao; Yoshihiro Kakeji; Hideaki Anai; Masaru Morita; Yoshinao Oda; Yoshihiko Maehara
Journal:  Gastric Cancer       Date:  2012-04-18       Impact factor: 7.370

5.  Expression of cyclooxygenase-2, p53 and Ki-67 in gastric cancer.

Authors:  Young-Eun Joo; Ik-Joo Chung; Young-Kyu Park; Yang-Seok Koh; Jae-Hyuk Lee; Chang-Hwan Park; Wan-Sik Lee; Hyun-Soo Kim; Sung-Kyu Choi; Jong-Sun Rew; Chang-Soo Park; Sei-Jong Kim
Journal:  J Korean Med Sci       Date:  2006-10       Impact factor: 2.153

6.  Effects of a Shuangling Fuzheng anticancer preparation on the proliferation of SGC-7901 cells and immune function in a cyclophosphamide-treated murine model.

Authors:  Hua-Sheng Chen; Jue Chen; De-Li Cui; Yuan-Yuan Zheng; Ai-Hua Xu; Gang Chen; Ling-Chang Jia
Journal:  World J Gastroenterol       Date:  2007-12-28       Impact factor: 5.742

7.  Therapeutic mechanism of ginkgo biloba exocarp polysaccharides on gastric cancer.

Authors:  Ai-Hua Xu; Hua-Sheng Chen; Bu-Chan Sun; Xiao-Ren Xiang; Yun-Fei Chu; Fan Zhai; Ling-Chang Jia
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

Review 8.  MYC and gastric adenocarcinoma carcinogenesis.

Authors:  Danielle-Queiroz Calcagno; Mariana-Ferreira Leal; Paulo-Pimentel Assumpcao; Marilia-Arruda-Cardoso Smith; Rommel-Rodriguez Burbano
Journal:  World J Gastroenterol       Date:  2008-10-21       Impact factor: 5.742

Review 9.  Perspectives on new biomarkers in gastric cancer: diagnostic and prognostic applications.

Authors:  Danilo do Rosário Pinheiro; Wallax Augusto Silva Ferreira; Mariceli Baia Leão Barros; Mariana Diniz Araújo; Symara Rodrigues-Antunes; Bárbara do Nascimento Borges
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

10.  Preoperative hepatic and regional arterial chemotherapy in the prevention of liver metastasis after colorectal cancer surgery.

Authors:  Jianmin Xu; Yunshi Zhong; Niu Weixin; Qin Xinyu; Lai Yanhan; Ren Li; Wang Jianhua; Yan Zhiping; Cheng Jiemin
Journal:  Ann Surg       Date:  2007-04       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.